﻿               SEQUENCE LISTING

<110> Helmholtz-Zentrum für Infektionsforschung

<120> HERPES REPORTER VIRUS FOR PHASE-SPECIFIC INTERROGATION OF THE VIRAL REPLICATION CYCLE

<130> 2147/17WO

<160> 9

<170> BiSSAP 1.3.6

<210> 1
<211> 140
<212> DNA
<213> Artificial Sequence


<220> 
<223> Modified viral sequence

<400> 1
tacccgtacc tgctcgacat gttccagctg ccgagccctc ggtgcttgaa gtcggaggac     60

ttcgtccggc cgctgcagct tctcttgggc ccgggctacc tcaggagacg gttctctttc    120

tacctgggac tgttgggact                                                140


<210> 2
<211> 123
<212> DNA
<213> Artificial Sequence


<220> 
<223> Modified viral sequence

<400> 2
tacctgctcg acatgttccc gtcacctctc ccgtctcctt cagacgattg tacgccactg     60

cagctcctct taggaccggg ttacagattg tggcgcggcc ctgggtgcca ccggttgttc    120

gcc                                                                  123


<210> 3
<211> 139
<212> DNA
<213> Artificial Sequence


<220> 
<223> Modified viral sequence

<400> 3
gacctcccta gcaaactggg gcacaagctt aatggctcgg gagccacgaa cttcagcctc     60

ctgaagcagg ccggcgacgt cgaagagaac ccgggcccga tggatctgcc tactaccgtc    120

gtgcgaaaat actggactt                                                 139


<210> 4
<211> 140
<212> DNA
<213> Artificial Sequence


<220> 
<223> Modified viral sequence

<400> 4
agtcccaaca gtcccaggta gaaagagaac cgtctcctga ggtagcccgg gcccaagaga     60

agctgcagcg gccggacgaa gtcctccgac ttcaagcacc gagggctcgg cagctggaac    120

atgtcgagca ggtacgggta                                                140


<210> 5
<211> 123
<212> DNA
<213> Artificial Sequence


<220> 
<223> Modified viral sequence

<400> 5
ggcgaacaac cggtggcacc cagggccgcg ccacaatctg taacccggtc ctaagaggag     60

ctgcagtggc gtacaatcgt ctgaaggaga cgggagaggt gacgggaaca tgtcgagcag    120

gta                                                                  123


<210> 6
<211> 139
<212> DNA
<213> Artificial Sequence


<220> 
<223> Modified viral sequence

<400> 6
aagtccagta ttttcgcacg acggtagtag gcagatccat cgggcccggg ttctcttcga     60

cgtcgccggc ctgcttcagg aggctgaagt tcgtggctcc cgagccatta agcttgtgcc    120

ccagtttgct agggaggtc                                                 139


<210> 7
<211> 47
<212> PRT
<213> Artificial Sequence


<220> 
<223> Modified viral sequence

<400> 7
Met Gly Met Asp Glu Leu Tyr Lys Val Asp Gly Ser Gly Ala Thr Asn 
1               5                   10                  15      
Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro 
            20                  25                  30          
Met Glu Ser Ser Ala Lys Arg Lys Met Asp Pro Asp Asn Pro Asp 
        35                  40                  45          

<210> 8
<211> 41
<212> PRT
<213> Artificial Sequence


<220> 
<223> Modified viral sequence

<400> 8
Met Asp Glu Leu Tyr Lys Gly Ser Gly Glu Gly Arg Gly Ser Leu Leu 
1               5                   10                  15      
Thr Cys Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ser Asn Thr Ala 
            20                  25                  30          
Pro Gly Pro Thr Val Ala Asn Lys Arg 
        35                  40      

<210> 9
<211> 46
<212> PRT
<213> Artificial Sequence


<220> 
<223> Modified viral sequence

<400> 9
Asp Leu Pro Ser Lys Leu Gly His Lys Leu Asn Gly Ser Gly Ala Thr 
1               5                   10                  15      
Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly 
            20                  25                  30          
Pro Met Asp Leu Pro Thr Thr Val Val Arg Lys Tyr Trp Thr 
        35                  40                  45      

